Hackensack Meridian CDI Scientists Discover New Tuberculosis Treatment Pathway
June 29, 2021
![](/-/media/Project/HMH/HMH/CDI/wp-content/uploads/2021/07/CDI-DickThomas-NTMpaper-Sideframe2.jpg)
The compound TA-C is metabolized by TB bacteria – weakening the germ from within like a ‘Trojan horse’ attack
Scientists from the Hackensack Meridian Center for Discovery and Innovation, working with collaborators from across the globe, uncovered the mechanism of action of a novel anti-tuberculosis drug that they have helped develop.